Arthramid

Follow us to keep up to date with the latest research and get clinical insights on Arthramid® 2.5% iPAAG hydrogel. Arthramid is a unique and patented hydrogel formulation consisting of 97.5% sterile water and 2.5% ILX cross-linked polyacrylamide combined in a sterile pre-filled 1ml syringe for intra-articular injection. Arthramid is used to treat non-infectious causes of joint lameness in animals, including both early and late stages of osteoarthritis. Arthramid has the ability to integrate into the synovial membrane creating a safe and inert ”bio-scaffold” supporting structure. The effect of this unique mechanism of action helps stabilise the joint capsule, increase elasticity, and contribute to reducing the pain of synovitis and osteoarthritis, and ultimately restoring the joint to normal function. Arthramid is a prescription veterinary medicine for administration by a Veterinarian.